Insulin resistance as a common clinical feature in diabetes mellitus, obesity, hypertension, dyslipidemia, and atherosclerosis deserves more attention in COVID-19
Guardado en:
Autor principal: | Abdolkarim Mahrooz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wolters Kluwer Medknow Publications
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ab16a58aeeeb4dcba6f3a950d6bb94b1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hyperosmolarity Deserves More Attention in Critically Ill COVID-19 Patients with Diabetes: A Cohort-Based Study
por: Gou L, et al.
Publicado: (2021) -
Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia
por: Marcela Doktorova, et al.
Publicado: (2017) -
ABCC6 deficiency promotes dyslipidemia and atherosclerosis
por: Christopher Brampton, et al.
Publicado: (2021) -
Maternal obesity in Africa: Is it time to pay more attention?
por: O.J. Onubi, et al.
Publicado: (2015) -
TREM-1 links dyslipidemia to inflammation and lipid deposition in atherosclerosis
por: Daniel Zysset, et al.
Publicado: (2016)